Table 4 Microbiological findings by use of the BioFire FilmArray Pneumonia panel plus versus standard microbiological methods in 24 patients with other respiratory tract infections.

From: Rapid syndromic PCR testing in patients with respiratory tract infections reduces time to results and improves microbial yield

Microbes

Other respiratory tract infections (other RTIs)

Total detections*

Detections deemeda relevant**

All methods combined

FAP plus

Standard methods

All methods combined

FAP plus

Standard methods

Viruses

24

24 (100)

20 (83)

24

24 (100)

20 (83)

Influenza A virus

13

13 (100)

13 (100)

13

13 (100)

13 (100)

Human metapneumovirus

3

3 (100)

2 (67)

3

3 (100)

2 (67)

Respiratory syncytial virus

4

4 (100)

3 (75)

4

4 (100)

3 (75)

Coronavirus

2

2 (100)

2

2 (100)

Parainfluenza virus

0

0 (–)

0 (–)

0

0 (–)

0 (–)

Rhino-/enterovirus

2

2 (100)

2 (100)

2

2 (100)

2 (100)

Bacteria

22

22 (100)

6 (27)

0

0 (–)

0 (–)

H. influenzae

10

10 (100)

4 (40)

0

0 (–)

0 (–)

S. pneumoniae

4

4 (100)

0 (0)

0

0 (–)

0 (–)

M. catarrhalis

3

3 (100)

1 (33)

0

0 (–)

0 (–)

E. coli

2

2 (100)

0 (0)

0

0 (–)

0 (–)

S. aureus

2

2 (100)

1 (50)

0

0 (–)

0 (–)

S. agalactiae

1

1 (100)

0 (0)

0

0 (–)

0 (–)

S. epidermidis

0

0 (–)

0

0 (–)

K. pneumoniae

0

0 (–)

0 (–)

0

0 (–)

0 (–)

S. marcescens

0

0 (–)

0 (–)

0

0 (–)

0 (–)

P. aeruginosa

0

0 (–)

0 (–)

0

0 (–)

0 (–)

Proteus spp.

0

0 (–)

0 (–)

0

0 (–)

0 (–)

K. oxytoca

0

0 (–)

0 (–)

0

0 (–)

0 (–)

A. calcoaceticusA. baumanii complex

0

0 (–)

0 (–)

0

0 (–)

0 (–)

E. cloacae complex

0

0 (–)

0 (–)

0

0 (–)

0 (–)

M. pneumoniae

0

0 (–)

0 (–)

0

0 (–)

0 (–)

L. pneumophila

0

0 (–)

0 (–)

0

0 (–)

0 (–)

Other detections

0

0 (–)

0

0 (–)

C. albicans

0

0 (–)

0

0 (–)

P. jirovecii

0

0 (–)

0

0 (–)

Total

46

46 (100)

26 (57)

24

24 (100)

20 (83)

  1. Microbiological findings provided by the syndromic PCR panel (FAP plus) compared to SDs in patients with other RTIs (n = 24). Detections deemed as clinically relevant a pathogens are further specified. *Data are shown as number of detections with percentage of the respective microbe’s total detections (All methods combined) in brackets. **Data are shown as number of relevant detections with percentage of the respective microbe’s total relevant detections (All methods combined) in brackets. Statistically significant differences (McNemar’s test, p < 0.05) between the FAP plus and SDs, are marked with bold fonts.
  2. RTI, respiratory tract infection; FAP plus, Biomérieux BioFire FilmArray Pneumonia panel plus; SDs, standard diagnostic methods; –, not applicable; FIA, fluorescent immunoassay.
  3. aThe clinical relevance of all detected microbes was evaluated retrospectively using pre-specified criteria (Supplementary material, S4).